Literature DB >> 9792908

Specific interaction between bovine cyclophilin A and synthetic analogues of cyclolinopeptide A.

P Gallo1, F Rossi, M Saviano, C Pedone, G Colonna, R Ragone.   

Abstract

Like cyclosporin A, cyclolinopeptide A binds specifically bovine cyclophilin A, inhibiting its peptidyl-prolyl cis-trans isomerase activity. We describe here the protein interaction with several synthetic analogues of cyclolinopeptide A, which are either homodetic or disulphide bridged heterodetic cyclopeptides characterized by different ring dimensions, in terms of dissociation and inhibition constants evaluated by fluorescence and inhibition of the enzyme activity, respectively. Dissociation constants from fluorescence experiments are practically identical and about 20-fold lower than for cyclosporin A. On the other hand, inhibition constants differ from compound to compound and are higher than for cyclosporin A. This result is therefore difficult to rationalize, but we would suggest decoupling between binding and inhibitory ability of cyclopeptides. The Pro1 residue of cyclolinopeptide A seems to play a fundamental role in determining the inhibition of the rotamase activity of cyclophilin A, as the homodetic analogue lacking this residue does not show any inhibitory ability. Similarly, heterodetic analogues with a ring size smaller than 7 residues do not display inhibition. We presume that the sequence -Pro-Pro-Phe-Phe- and a ring size of 8 residues for homodetic cyclic peptides could be used as starting points in the targeted synthesis of cyclopeptides able to bind both cyclosporin A and calcineurin. The only peptide showing similar values of the dissociation and inhibition constant is cyclolinopeptide A. This compound can be considered a novel model for the molecular design of immunosuppressant drugs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9792908     DOI: 10.1093/oxfordjournals.jbchem.a022202

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  3 in total

1.  Antiviral Activity of a Cyclic Pro-Pro-β3-HoPhe-Phe Tetrapeptide against HSV-1 and HAdV-5.

Authors:  Ewa Zaczyńska; Krzysztof Kaczmarek; Janusz Zabrocki; Jolanta Artym; Michał Zimecki
Journal:  Molecules       Date:  2022-05-31       Impact factor: 4.927

Review 2.  Effects of Modifications on the Immunosuppressive Properties of Cyclolinopeptide A and Its Analogs in Animal Experimental Models.

Authors:  Michał Zimecki; Krzysztof Kaczmarek
Journal:  Molecules       Date:  2021-04-27       Impact factor: 4.411

Review 3.  Flaxseed Lignans as Important Dietary Polyphenols for Cancer Prevention and Treatment: Chemistry, Pharmacokinetics, and Molecular Targets.

Authors:  S Franklyn De Silva; Jane Alcorn
Journal:  Pharmaceuticals (Basel)       Date:  2019-05-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.